Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 28;10(1):359.
doi: 10.1186/s13287-019-1484-6.

Functional proteins of mesenchymal stem cell-derived extracellular vesicles

Affiliations
Review

Functional proteins of mesenchymal stem cell-derived extracellular vesicles

Guanguan Qiu et al. Stem Cell Res Ther. .

Abstract

Extracellular vesicles (EVs) contain proteins, microRNAs, mRNAs, long non-coding RNAs, and phospholipids, and are a novel mechanism of intercellular communication. It has been proposed that the immunomodulatory and regenerative effects of mesenchymal stem/stromal cells (MSCs) are mainly mediated by soluble paracrine factors and MSC-derived EVs (MSC-EVs). Recent studies suggest that MSC-EVs may serve as a novel and cell-free alternative to whole-cell therapies. The focus of this review is to discuss the functional proteins which facilitate the effects of MSC-EVs. The first section of the review discusses the general functions of EV proteins. Next, we describe the proteomics of MSC-EVs as compared with their parental cells. Then, the review presents the current knowledge that protein contents of MSC-EVs play an essential role in immunomodulation and treatment of various diseases. In summary, functional protein components are at least partially responsible for disease-modulating capacity of MSC-EVs.

Keywords: Exosomes; Extracellular vesicles; Functional proteins; Mesenchymal stem/stromal cells; Microvesicles.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

Cited by

References

    1. Zheng G, Huang L, Tong H, Shu Q, Hu Y, Ge M, Deng K, Zhang L, Zou B, Cheng B, Xu J. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respir Res. 2014;15:39. doi: 10.1186/1465-9921-15-39. - DOI - PMC - PubMed
    1. Florea V, Rieger AC, DiFede DL, El-Khorazaty J, Natsumeda M, Banerjee MN, Tompkins BA, Khan A, Schulman IH, Landin AM, et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (the TRIDENT study) Circ Res. 2017;121:1279–1290. doi: 10.1161/CIRCRESAHA.117.311827. - DOI - PMC - PubMed
    1. Smets Françoise, Dobbelaere Dries, McKiernan Patrick, Dionisi-Vici Carlo, Broué Pierre, Jacquemin Emmanuel, Lopes Ana Isabel, Gonçalves Isabel, Mandel Hanna, Pawlowska Joanna, Kamińska Diana, Shteyer Eyal, Torre Giuliano, Shapiro Riki, Eyskens François, Clapuyt Philippe, Gissen Paul, Pariente Danièle, Grunewald Stephanie, Yudkoff Marc, Binda Maria Mercedes, Najimi Mustapha, Belmonte Nathalie, de Vos Beatrice, Thonnard Joelle, Sokal Etienne. Phase I/II Trial of Liver–derived Mesenchymal Stem Cells in Pediatric Liver–based Metabolic Disorders. Transplantation. 2019;103(9):1903–1915. doi: 10.1097/TP.0000000000002605. - DOI - PubMed
    1. Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750. doi: 10.1080/20013078.2018.1535750. - DOI - PMC - PubMed
    1. Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75:193–208. doi: 10.1007/s00018-017-2595-9. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources